Skip to main content
Clinical Trials/IRCT20220305054184N2
IRCT20220305054184N2RecruitingPhase 3

The effect of Ghost oil on the treatment and relief of pain caused by diabetic neuropathy in a double-blind, parallel-controlled randomized clinical trial

Kermanshah University of Medical Sciences0 sites86 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
86

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • The main complaint of tingling
  • Pain in the distal region of the lower limb for at least 3 months
  • Clinical diagnosis of painful diabetic poly neuropathy plus a minimum score equal to or higher than 4 in the clinical evaluation of diabetic neuropathy (DN4 – Questionnaire)
  • History of type 2 diabetes for at least 3 years
  • Age over 18 years
  • Chronic diabetic neuropathy

Exclusion Criteria

  • Lower limb pain caused by other diseases such as peripheral vascular disease and radiculopathy
  • History of skin allergies to herbs
  • Diabetic foot ulcers
  • Taking other medications to treat diabetic neuropathy
  • Drug addiction
  • Taking anticoagulants
  • Fractures and traumatic injuries lead to sensory and motor injuries in the lower extremities
  • Autoimmune diseases (rheumatism and MS)
  • History of hereditary neuropathies or underlying diseases that cause neuropathy such as chronic uremia
  • lower limb amputation

Investigators

Similar Trials